KFGK
NVS icon

Keystone Financial Group (Kentucky)’s Novartis NVS Stock Holding History

Keystone Financial Group (Kentucky)’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$345K Buy
2,280
+55
+2% +$8.43K 0.02% 367
2025
Q4 		$307K Buy
+2,225
New +$291K 0.02% 350
2025
Q3 		– Sell
-1,700
Closed -$204K – 466
2025
Q2 		$204K Buy
+1,700
New +$192K 0.02% 398

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Keystone Financial Group (Kentucky)'s NVS Position: Q1 2026 in Review

Keystone Financial Group (Kentucky) increased its Novartis (NVS) stake by 2.5% in Q1 2026, buying an estimated $8.43K and bringing the position to 2,280 shares worth $345K. The position accounts for 0.02% of the portfolio, ranked #367.

Keystone Financial Group (Kentucky) first reported a position in NVS in Q2 2025 and has held it in 3 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Keystone Financial Group (Kentucky) held 2,280 shares of Novartis worth $345K as of Q1 2026.
  • Keystone Financial Group (Kentucky) bought 55 Novartis shares in Q1 2026, an estimated $8.43K.
  • Novartis made up 0.02% of Keystone Financial Group (Kentucky)'s portfolio in Q1 2026, its #367 holding.
  • Keystone Financial Group (Kentucky) first reported a position in Novartis in Q2 2025 and has held it in 3 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q1 2026, filed 13 May 2026.